Main Article Content

Concurrent chemo-radiation induced renal and haematological toxicities in patients with invasive cervical cancer undergoing treatment


P Pillay
K Govender

Abstract

Background. Cervical cancer constitutes a major problem in women’s health in South Africa (SA). Concurrent chemo-radiation is the standardised treatment for patients with invasive cervical cancer. There is limited evidence on the differences in the concurrent chemo-radiation treatment toxicity between HIV-positive and HIV-negative patients.


Objective. To determine the renal and haematological toxicities associated with concurrent chemo-radiation in women undergoing treatment for invasive cervical cancer, using renal and haematological biomarkers.


Methods. A prospective study was conducted among 82 women that presented for concurrent chemo-radiation treatment at the Inkosi Albert Luthuli Central Hospital in SA. Thirty two (39%) of participants were HIV-positive. Data collected using questionnaires and the hospital’s databases were analysed with SPSS data analysis software. Toxicity was scored using the Cooperative Group Common Toxicity Criteria.


Results. More than 90% of both HIV-positive and HIV-negative participants completed all 5 cycles of chemotherapy. The main finding in both cohorts was Grade 1 and 2 haematological toxicity. Haemoglobin was significantly decreased in 74% of participants. No renal toxicity was identified in this study. The reasons for not completing treatment were abscondment during treatment (3%) and discontinuation of treatment by the physician (1%).


Conclusion. Concurrent chemo-radiation was well tolerated in both HIV-positive and HIV-negative participants. The same concurrent chemo-radiation protocol can be applied to both HIV-positive and HIV-negative patients. However, the study population was small and findings need to be replicated in more extensive studies.

     View our Diamond Open Access Survey (closes on February 29, 2024)


Journal Identifiers


eISSN: 2305-8862
print ISSN: 0038-2329